References
Leung N, Griffin MD, Dispenzieri A, Haugen EN, Gloor JM, Schwab TR et al. Living donor kidney and autologous stem cell transplantation for primary systemic amyloidosis (AL) with predominant renal involvement [see comment]. Am J Transplant 2005; 5: 1660–1670.
Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008; 8: 753–760.
Nakamura H, Nakao T, Ujiie H, Karasuno T, Teshima H, Komatsu K et al. Induction of autologous graft-versus-host disease after autologous peripheral blood stem cell transplantation. J Allergy Clin Immunol 1999; 103: S457–S461.
Prud’homme GJ, Parfrey NA, Vanier LE . Cyclosporine-induced autoimmunity and immune hyperreactivity. Autoimmunity 1991; 9: 345–356.
Barraclough KA, Robinson KL, Dowling JP, Schwarer AP, Perry GJ . Renal graft rejection after allogeneic peripheral-blood stem cell transplantation. Am J Kidney Dis 2006; 48: 822–826.
Neumann F, Graef T, Tapprich C, Vaupel M, Steidl U, Germing U et al. Cyclosporine A and mycophenolate mofetil vs cyclosporine A and methotrexate for graft-versus-host disease prophylaxis after stem cell transplantation from HLA-identical siblings [see comment]. Bone Marrow Transplant 2005; 35: 1089–1093.
Nieto Y, Patton N, Hawkins T, Spearing R, Bearman SI, Jones RB et al. Tacrolimus and mycophenolate mofetil after nonmyeloablative matched-sibling donor allogeneic stem-cell transplantations conditioned with fludarabine and low-dose total body irradiation. Biol Blood Marrow Transplant 2006; 12: 217–225.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Leung, N., Gloor, J., Dean, P. et al. Acute cellular rejection in a renal allograft immediately following leukocyte engraftment after auto-SCT. Bone Marrow Transplant 43, 345–346 (2009). https://doi.org/10.1038/bmt.2008.320
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2008.320
- Springer Nature Limited